Skip to main content
Clinical Trials/NL-OMON27745
NL-OMON27745
Completed
Not Applicable

BONDS: Boosting Oxytocin after trauma: Neurobiology and the Development of Stress-related psychopathology .

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PTSD, trauma-related psychopathology
Sponsor
Academic Medical Center - University of Amsterdam
Enrollment
220
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Olff, M., W. Langeland, A. Witteveen, D. Denys, 2010. A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder. CNS spectr., v. 15, no. 8, p. 522-30.

Frijling, J. L., van Zuiden, M., Koch, S. B., Nawijn, L., Goslings, J. C., Luitse, J. S., ... & Olff, M. (2014). Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial. BMC psychiatry, 14(1), 92.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Presentation at the Trauma Unit or Emergency Department after a potentially traumatic event, according to PTSD A1 criterion in the DSM\-IV;
  • 2\. Trauma Screening Questionnaire (TSQ) ≥ 5, or Peritraumatic Distress Inventory (PDI) ≥ 17 between 24 and 72 hours after trauma exposure;

Exclusion Criteria

  • 1\. Any severe or chronic systemic disease;
  • 2\. Current psychotic, bipolar, substance\-related, severe personality disorder, or mental retardation;

Outcomes

Primary Outcomes

Not specified

Similar Trials